PHARMAZAN PHARMACEUTICALS ApS: Financial statements 2023
CVR: 32478697
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMAZAN PHARMACEUTICALS ApS (CVR 32478697) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -36,283 and a net result of DKK -38,360 compared with DKK -27,691 the year before. Equity in the 2023 report amounted to DKK -1,797.
- Gross Profit
- DKK -36,283
- Profit/Loss
- DKK -38,360
- Equity
- DKK -1,797
- Total Assets
- DKK 52,293
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -36 t. | -38 t. | -2 t. | 0 |
| 2022 | - | -26 t. | -28 t. | 37 t. | 0 |
| 2021 | - | -112 t. | -115 t. | 64 t. | 0 |
| 2020 | - | 144 t. | 111 t. | 330 t. | - |
| 2019 | - | 455 t. | 434 t. | 567 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMAZAN PHARMACEUTICALS ApS has published its annual report for 2022. Gross profit came to DKK -26,473, and the net result was DKK -27,691.
About PHARMAZAN PHARMACEUTICALS ApS
PHARMAZAN PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens Otto Tram. The company is owned by HELSEFARMA ApS and TRAM HOLDING ApS. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -21,837 and a net result of DKK -21,837 compared with DKK -40,416 the year before. Equity in the 2025 report amounted to DKK -64,051.